WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics

NEW YORK, Sept. 7  /PRNewswire-FirstCall/ -- Richard Gabriel, Chief Executive Officer of DNAPrint Genomics, Inc. (OTC:DNAG) (BULLETIN BOARD: DNAG)  (http://www.dnaprint.com/) will be featured in an exclusive interview with http://www.wallst.net/ that is scheduled to take place on September 10 at 11 a.m. EDT. The interview will be posted on http://www.wallst.net/ by 8 p.m. EDT on September 10.

The interview will cover topics including DNAPrint Genomics' market potential, growth initiatives, competitive edge, recent news, and milestones for which investors should watch.

To hear the interview in its entirety, visit http://www.wallst.net/, and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section of the site, or by entering the company's ticker symbol in the Search Archive window on the right-hand column of the "Interviews" section.

About DNAPrint Genomics:

DNAPrint(TM) Genomics, Inc. is a developer of genomics-based products and services in two primary markets: biomedical and forensics. DNAPrint Pharmaceuticals, Inc., a wholly owned subsidiary, develops diagnostic tests and theranostic products (drug/test combinations) using the Company's proprietary ancestry-informed genetic marker studies combined with proprietary computational modeling technology. Computational Biology and Pharmacogenomics services are also offered externally to biopharmaceutical companies. The Company's first theranostic product is PT-401, a "Super EPO" (erythropoietin) dimer protein drug for the treatment of anemia in renal dialysis patients (with end stage renal disease). DNAPrint is proud of its continued dedication to developing and supplying new technological advances in law enforcement and consumer ancestry heritage interests.

For more information about the company, please visit http://www.dnaprint.com/.

About WallSt.net:

http://www.wallst.net/ is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com/). The Web site is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net/, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com/), a provider of media and compliance solutions to publicly traded companies. In addition to WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio (http://www.wallstradio.com/), a business and finance podcast Web site. Financial Filings Corp. is expecting to receive two hundred eighty dollars from DNAPrint Genomics, Inc. for the dissemination of this press release. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

  (Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)

  Contact:  WallSt.net
            800-4-WALL-ST


DATASOURCE: Financial Filings Corp.



CONTACT:  WallSt.net, 1-800-4-WALL-ST



Web site:  http://www.financialfilings.com/

http://www.wallst.net/

http://www.dnaprint.com/ 

Copyright